ARYx Therapeutics, Inc.

ARYX · OTC
Analyze with AI
12/31/2009
12/31/2008
12/31/2007
12/31/2006
Assets
Cash & Equivalents$7,409$35,999$55,476$18,660
Short-Term Investments$353$8,588$7,640$31,648
Receivables$0$0$0$45
Inventory$0$0$0$0
Other Curr. Assets$1,045$381$1,783$1,058
Total Curr. Assets$8,807$45,850$64,899$51,411
Property Plant & Equip (Net)$2,258$3,198$3,655$4,169
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$1,341$2,100$1,071$1,184
Total NC Assets$3,599$5,298$4,726$5,353
Other Assets$0$0$0$0
Total Assets$12,406$51,148$69,625$56,764
Liabilities
Payables$685$2,454$1,369$691
Short-Term Debt$5,183$3,737$3,536$3,197
Tax Payable$0$0$0$0
Deferred Revenue$0$4,828$3,913$3,896
Other Curr. Liab.$2,813$4,828$4,639$3,743
Total Curr. Liab.$8,681$11,019$13,457$11,527
LT Debt$6,641$12,714$3,444$6,679
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$17,377$132,270
Total NC Liab.$6,641$12,714$20,821$138,949
Other Liabilities$0$0$0$0
Cap. Leases$1,386$1,769$0$0
Total Liabilities$15,322$23,733$34,278$150,476
Equity
Pref Stock$0$0$0$0
Common Stock$28$27$18$1
Retained Earnings-$187,109-$153,942-$122,724-$95,163
AOCI$0$45$0$0
Other Equity$184,165$181,285$158,053$1,450
Total Equity-$2,916$27,415$35,347-$93,712
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$12,406$51,148$69,625$56,764
Net Debt$4,415-$19,548-$48,496-$8,784